US20150218210A1 - Molecular separation device - Google Patents
Molecular separation device Download PDFInfo
- Publication number
- US20150218210A1 US20150218210A1 US14/686,452 US201514686452A US2015218210A1 US 20150218210 A1 US20150218210 A1 US 20150218210A1 US 201514686452 A US201514686452 A US 201514686452A US 2015218210 A1 US2015218210 A1 US 2015218210A1
- Authority
- US
- United States
- Prior art keywords
- separation membrane
- membrane
- components
- chamber
- outer periphery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000926 separation method Methods 0.000 title claims abstract description 71
- 239000012528 membrane Substances 0.000 claims abstract description 105
- 238000000034 method Methods 0.000 claims abstract description 24
- 239000007900 aqueous suspension Substances 0.000 claims abstract description 17
- 230000000737 periodic effect Effects 0.000 claims abstract description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 40
- 229910021389 graphene Inorganic materials 0.000 claims description 36
- 230000009919 sequestration Effects 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 230000005012 migration Effects 0.000 claims description 9
- 238000013508 migration Methods 0.000 claims description 9
- 230000014759 maintenance of location Effects 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 description 58
- 108090000623 proteins and genes Proteins 0.000 description 58
- 239000000463 material Substances 0.000 description 15
- 239000000725 suspension Substances 0.000 description 9
- 239000010410 layer Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 208000031220 Hemophilia Diseases 0.000 description 2
- 208000009292 Hemophilia A Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 229960000301 factor viii Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000001020 plasma etching Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002064 nanoplatelet Substances 0.000 description 1
- 239000002074 nanoribbon Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/24—Extraction; Separation; Purification by electrochemical means
- C07K1/26—Electrophoresis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/02—Inorganic material
- B01D71/021—Carbon
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D35/00—Filtering devices having features not specifically covered by groups B01D24/00 - B01D33/00, or for applications not specifically covered by groups B01D24/00 - B01D33/00; Auxiliary devices for filtration; Filter housing constructions
- B01D35/06—Filters making use of electricity or magnetism
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D57/00—Separation, other than separation of solids, not fully covered by a single other group or subclass, e.g. B03C
- B01D57/02—Separation, other than separation of solids, not fully covered by a single other group or subclass, e.g. B03C by electrophoresis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/422—Electrodialysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/425—Electro-ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/12—Composite membranes; Ultra-thin membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/02—Inorganic material
- B01D71/021—Carbon
- B01D71/0211—Graphene or derivates thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/20—Specific permeability or cut-off range
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/18—Apparatus therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
Definitions
- This invention uses a perforated and selectively charged membrane to isolate charged species.
- the present invention utilizes the charged membrane to isolate biologically active proteins from solution by means of molecular weight, size and molecule resonant mode dynamics.
- the invention utilizes the charged membrane to isolate compounds such as ions, polymer slurries and biologically active proteins that are currently very difficult to remove from solution in effective percentage yield, and require extensive energy usage.
- Most biologically active proteins are ionically charged at their extremities.
- the proteins are moderately soluble in water and remain polar in that condition.
- Many disease-treating proteins are harvested from living tissue or in bulk in Vitro solutions. These include low animal plasma slurries including, but not limited to interferon (human and selected hominid), insulin (bovine and synthetic hominid), and cascade clotting factor VIII for hemophilia.
- Current methods rely on capillary action to “stall” the desired protein at a specific location and invoke subsequent action (such as rinsing and/or diffusion), to gradually recover the isolated protein of interest. The resulting protein removal frequently traumatizes and de-natures the protein.
- Rinsing must “rip” the protein from the many-thousand nanometer deep porosity surface on which it is held. Typical permeates (the output of the harvester) must be further centrifuged to deliver pharmaceutical grade reagents. Current sequestration membranes and porous tubes are believed to be quite thick and therefore their thickness ratio is less flow efficient.
- porous separation membrane is perforated graphene.
- the above embodiment could provide for collecting the migrated components in at least one collection well disposed on the separation membrane's outer periphery, or provide for utilizing perforated graphene as the porous separation membrane.
- FIG. 1 is a schematic drawing of a molecular separation device according to the concepts of the present invention
- FIG. 2 is a schematic drawing of a chamber maintaining a separation membrane according to the concepts of the present invention
- FIG. 3 is schematic representation of a protein collected by the separation membrane according to the concepts of the present invention.
- FIG. 4 illustrates the “walking” or charged migration of the protein during operation of the device according to the concepts of the present invention.
- a molecular separation device according to the concepts of the present invention is designated generally by the numeral 10 .
- the device 10 includes a chamber 12 which at one end has an inlet 14 for receiving an aqueous suspension which contains the material or component which is to be removed. In the present embodiment, proteins are to be separated from the suspension.
- the chamber 12 also provides for an outlet 16 , opposite the inlet, in which the secondary products or the “unfiltered” products are exhausted or drained from the chamber.
- a separation membrane 18 is held by the chamber 12 so as to be orthogonal to the flow of the aqueous suspension.
- the separation membrane is a porous material such as a carbon membrane.
- a graphene membrane is used, and in other embodiments multiple layers of graphene material may be used.
- the separation membrane 18 is a graphene membrane as described in U.S. Pat. No. 8,361,321, which is incorporated herein by reference.
- the graphene membrane is a single-atomic-layer-thick layer of carbon atoms, bound together to define a sheet.
- the thickness of a single graphene membrane which may be referred to as a layer or a sheet, is approximately 0.2 to 0.3 nanometers (nm).
- multiple graphene layers can be formed, having greater thickness and correspondingly greater strength.
- Multiple graphene sheets can be provided in multiple layers as the membrane is grown or formed, and is commonly known as few layer graphene. Or multiple graphene sheets can be achieved by layering or positioning one graphene layer on top of another.
- a single layer of graphene or multiple graphene layers may be used. Testing reveals that multiple layers of graphene maintain their integrity and function, possibly as a result of self-adhesion. This improves the strength of the membrane and in some cases flow performance.
- the perforated graphene high-flux throughput material provides significantly improved filtration properties, as opposed to polyamide or other polymeric material filtration materials.
- the carbon atoms of the graphene layer define a repeating pattern of hexagonal ring structures (benzene rings) constructed of six carbon atoms, which form a honeycomb lattice of carbon atoms. An interstitial aperture is formed by each six carbon atom ring structure in the sheet and this interstitial aperture is less than one nanometer across.
- interstitial aperture is believed to be about 0.23 nanometers across at its longest dimension. Accordingly, the dimension and configuration of the interstitial aperture and the electron nature of the graphene precludes transport of any molecule across the graphene's thickness unless there are perforations. This dimension is much too small to allow the passage of either water or ions.
- a representative generally or nominally round aperture or perforation 19 is defined through the graphene membrane 18 .
- the generally round shape of the aperture 19 is affected by the fact that the edges of the aperture are defined, in part, by the hexagonal carbon ring structure of the graphene membrane 18 .
- Aperture sizes may be selected depending upon the constituents of the received aqueous suspension and the constituents or components of the suspension that is desired to be blocked or filtered. Accordingly, the apertures 19 may range in size from 0.5 nm to 1.2 nm in some embodiments, or from 1.0 to 10 nm in other embodiments. And in other embodiments, the size of the apertures may range from 10 nm to 100 nm. Some apertures may be about 20 nm in some embodiments and about 50 nm in diameter in other embodiments.
- Apertures in the graphene membrane may be made by selective oxidation, by which is meant exposure to an oxidizing agent for a selected period of time. It is believed that the aperture 312 can also be laser-drilled.
- the most straightforward perforation strategy is to treat the graphene film with dilute oxygen in argon at elevated temperature. As described therein, through apertures or holes in the 20 to 180 nm range were etched in graphene using 350 mTorr of oxygen in 1 atmosphere (atm) argon at 500° C. for 2 hours. The paper reasonably suggests that the number of holes is related to defects in the graphene sheet and the size of the holes is related to the residence time.
- the structures may be graphene nanoplatelets and graphene nanoribbons.
- apertures in the desired range can be formed by shorter oxidation times.
- Another more involved method as described in Kim et al. “ Fabrication and Characterization of Large Area, Semiconducting Nanoperforated Graphene Materials ,” Nano Letters 2010 Vol. 10, No. 4, Mar. 1, 2010, pp 1125-1131 utilizes a self assembling polymer that creates a mask suitable for patterning using reactive ion etching.
- a P(S-blockMMA) block copolymer forms an array of PMMA columns that form vias for the RIE upon redeveloping.
- the pattern of holes is very dense.
- the number and size of holes is controlled by the molecular weight of the PMMA block and the weight fraction of the PMMA in the P(S-MMA). Either method has the potential to produce perforated graphene sheets. Other methods of forming the apertures may be employed. In the embodiments disclosed herein, it will be appreciated that the apertures are sized to block selected components of the suspension and allow passage of other components. Moreover, the edges of the apertures may be modified to assist in blocking or passing of selected components.
- a charging device designated generally by the numeral 20 , is connected to the separation membrane 18 so as to selectively apply an electrical charge to the material as the aqueous suspension is flowing through the material. Details of this process will be described as the description proceeds.
- a pump 24 may be coupled to the inlet 14 so as to control the flow of the aqueous suspension through the chamber 12 .
- the charging device 20 includes a controller designated generally by the numeral 28 .
- the controller 28 includes the necessary hardware, software, memory, and functionalities to control operation of the pump 24 and the separation membrane 18 so as to operate the device in a manner to be described.
- an input/output device 30 such as a keyboard so as to allow for a technician to operate the device 10 . This may be done by controlling the operation of the pump so as to control the amount of suspension flowing through the chamber and/or the operation of the charging device so as to control the amount of electrical voltage and/or current applied to the separation membrane 18 .
- the controller 28 sends an appropriate control signal through a digital/analog converter 32 , which generates a charge gradient that is applied to a driving circuit 34 .
- the driving circuit 34 generates signals that are delivered along driving leads 36 A and 36 B to locations on the separation membrane 18 .
- a ground connection 40 is provided to connect the separation membrane to ground while a return lead 42 is also connected to the separation membrane so as to provide a way of monitoring the status of the separation membrane during operation.
- the return lead 42 is connected to an analog/digital converter 44 which delivers a digital signal back to the controller 28 for observation by a technician.
- the chamber 12 orthogonally maintains the separation membrane 18 so as to be fully exposed to the suspension flowing through the chamber.
- the membrane 18 is carried or supported by appropriate ledges, ridges or any other support structure maintained within the chamber 12 .
- a polymeric supporting layer with openings much larger than apertures 19 may also be positioned underneath the membrane.
- micro-capture wells 50 Positioned about the outer circumference of the separation membrane are micro-capture wells 50 which allow for collection of the proteins that are blocked or collected by the separation membrane. These wells 50 are coupled to capture conduits 52 which deliver the desired protein material to a collection vessel 54 . The remaining uncaptured material exits the outlet 16 .
- the separation membrane is a sterile, hydrophobic, selectively perforated and charge bearing material.
- the size of the perforations or apertures 19 are selected in accordance with the best known practice for size exclusion i.e. passing, of unwanted material together with desired sequestration (capture) of the desired class of target proteins.
- Skilled artisans will appreciate that the aqueous suspension is crudely centrifuged or pre-filtered to remove the largest and ineffective protein sequastra i.e. the undesired and potentially membrane clogging mixture or components.
- the separation membrane is positioned orthogonally to the bulk mix flow of the aqueous suspension.
- the suspension could be a solvated plasma that includes the desired protein of interest.
- the suspension flows past the separation member and permits transport of unwanted smaller auxiliary proteins together with a class of target proteins for harvest. This will result in a distribution of both target and unwanted proteins against the separation membrane by convective pressure force.
- the suspension may be directed tangentially along the surface of the membrane 18 . Those components in the suspension smaller than the apertures 19 flow through the membrane and are processed accordingly.
- the present invention utilizes the electro-mechanically excited response of biologically active proteins that are commonly used for static constant potential (voltage) electrophoresis separation methods.
- the driving circuit 34 excites the separation membrane 18 and generates a periodic electrical charge over time to gradually migrate specific individual proteins of interest—identified as protein 60 —that are held by the separation membrane to the outer circumference of the membrane as schematically represented in FIG. 3 .
- application of a selected charge to the leads 36 A,B at selective times allows for generation of the “walking” movements of the proteins.
- charges may intermittently be applied to each lead so as to initiate the walking action of the protein.
- the selected proteins of interest are driven to the external circumference of separation membrane.
- application of a charge causes one end of the protein to extend outwardly toward the periphery of the membrane. Removal of the charge causes the end of the protein that did not move during the application of the charge to migrate toward the end of the protein that did move.
- Application of a periodic charge is believed to be suitable for proteins that are of a tubular or string-like shape.
- the aforementioned charges themselves may be generated in a standing wave pattern by the driving circuit 34 whose net outward motion may be caused by appropriate control of the charge phasing.
- the protein 16 effectively rides the wave as it moves outwardly to the periphery of the membrane 18 .
- Application of a standing wave is believed to be suitable for proteins that are of a spherical or globular shape. Once the proteins are driven to the circumference, they flow into the U-shaped capture well 50 as they are driven by weak gravitation and Van der Waals forces so as to capture and concentrate the selected protein.
- the controller 28 together with the driving circuit 34 provides for effectively producing the desired charge in space and time needed to migrate these specific proteins across the separation membrane to the capture wells 50 .
- the material then migrates from the wells through the conduits into the appropriate retention vessel 54 .
- periodic electrical charge effecting migration of desired molecules or proteins 60 is tuned to asymmetric normal modes of the desired components, thereby causing their rectilinear motion toward the separation membrane's outer periphery for sequestration.
- the periodic charge effecting migration of desired molecules or proteins 60 is controlled by a standing wave emanating from the membrane's inner diameter to the membrane's outer diameter, and thereby causing their rectilinear motion toward the separation membrane's periphery for sequestration.
- the separation membrane is a monatomic carbon graphene membrane with a selected hole diameter and spacing.
- very specific and selective forcing of the desired harvested molecules and/or proteins take place along the separation membrane surface so that they migrate to an awaiting capture basin at the outer circumference.
- one end of the protein 60 which is larger than the aperture 19 , extends toward the outer periphery of the membrane.
- the protein is moved by the alternating charge generating a second harmonic mode that causes a temporary physical change in the protein's shape.
- the other end of the protein detaches with little or no damage from the surface of the membrane and moves toward the first end of the protein. This process repeats until the protein is captured in the well 50 .
- This is represented in FIG. 4 by the time sequence A through E, where A represents the initial application of charge and E represents the last removal of charge as the protein reaches the membrane's outer periphery.
- the device 10 By controlling the hole diameter and the charge versus time profile, the device 10 obtains an accurate selectivity, purity and throughput not obtainable by prior art devices.
- Applications of this device include but are not limited to pharamacologic, hydrocarbon slurry refining and biomedical. Pharamacological applications allow for retrieval of high-value proteins from large amounts of water.
- the hydrocarbon slurry refining allows for stage filters based on hydrocarbon chain size in a micro-refinery fashion instead of heat/energy intensive distillation processes.
- the biomedical process allows for use of the device 10 in dialysis filters so as to filter impurities from the bloodstream.
- the disclosed device provides for creating a biological material filtration and isolation membrane that allows for unique, predictable and efficient migration of selected and specified biologically active proteins into sequestration upon demand.
- the device is also capable of controlling the precise molecular and electro-active nature of the required target molecules. It is further believed that the disclosed device can operate at significantly improved rates and quantity efficiency compared to current devices.
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 13/804,085, filed Mar. 14, 2013, which claims the benefit of and priority to U.S. Provisional Application Ser. No. 61/613,578, filed Mar. 21, 2012, each of which is hereby incorporated by reference in its entirety.
- This invention uses a perforated and selectively charged membrane to isolate charged species. In particular, the present invention utilizes the charged membrane to isolate biologically active proteins from solution by means of molecular weight, size and molecule resonant mode dynamics. Specifically, the invention utilizes the charged membrane to isolate compounds such as ions, polymer slurries and biologically active proteins that are currently very difficult to remove from solution in effective percentage yield, and require extensive energy usage.
- Isolation and recovery of biologically active proteins is currently very difficult. Current solutions rely on energy intensive methods such as evaporative/diffusive, electrophoresis and porous tube adhesion. These methods are utilized to remove undesired ions or compounds from solutions. One example of such a method is reverse osmosis. In some instances, no methodologies exist to remove the undesired ion or compound.
- Current systems for recovering biologically active protein for treatment of autoimmune deficiencies, AIDS, Hemophilia Lupus and the like are inadequate due to low yield, the requirements for labor-intensive operations, and costs. Specific examples of these 20-50 nm length-50,000 Dalton proteins are interferon, insulin, and clotting factor VIII. Current methods such as porous tube adhesion use ultra-filtration to isolate and then manually harvest the proteins. Unfortunately, tube thickness impedes flow of solvent plasmas and disrupts the protein's integrity resulting in low yield of the process.
- Most biologically active proteins are ionically charged at their extremities. The proteins are moderately soluble in water and remain polar in that condition. Many disease-treating proteins are harvested from living tissue or in bulk in Vitro solutions. These include low animal plasma slurries including, but not limited to interferon (human and selected hominid), insulin (bovine and synthetic hominid), and cascade clotting factor VIII for hemophilia. Current methods rely on capillary action to “stall” the desired protein at a specific location and invoke subsequent action (such as rinsing and/or diffusion), to gradually recover the isolated protein of interest. The resulting protein removal frequently traumatizes and de-natures the protein. Rinsing must “rip” the protein from the many-thousand nanometer deep porosity surface on which it is held. Typical permeates (the output of the harvester) must be further centrifuged to deliver pharmaceutical grade reagents. Current sequestration membranes and porous tubes are believed to be quite thick and therefore their thickness ratio is less flow efficient.
- Therefore, there is a need in the art for sequestration membranes, which are much thinner but still allow for efficient collection of proteins. Moreover, there is a need in the art for a device that separates proteins without damaging the protein during the collection and removal process.
- In light of the foregoing, it is a first aspect of the present invention to provide a molecular separation device.
- It is another aspect of the present invention to provide a first embodiment of a molecular separation device, comprising a chamber having an inlet and an outlet through which flows an aqueous suspension, a porous separation membrane positioned in the chamber substantially orthogonally to the flow of the aqueous suspension, and an electrical charging device connected to the separation membrane to apply a periodic electric charge so as to collect components blocked by the porous separation membrane.
- It is another aspect of the present invention for the above embodiment to provide a pump to control the flow of the aqueous suspension through the chamber.
- It is yet another aspect of the present invention for the above embodiment to provide a controller connected to the pump and the charging device, wherein the controller synchronizes flow of the aqueous suspension through the chamber and application of the periodic electric charge to the porous separation membrane.
- It is still another aspect of the present invention for the above embodiment to provide at least one collection well disposed on an outer periphery of the porous separation membrane to collect components blocked by the porous separation membrane.
- It is a further aspect of the present invention for the above embodiment to provide a conduit associated with each collection well to transfer collected components to a retention vessel.
- It is an aspect of the first embodiment of the present invention to provide the porous separation membrane is perforated graphene.
- It is another aspect of the first embodiment of the present invention to provide the periodic electrical charge effecting migration of desired molecules so that it is tuned to asymmetric normal modes of the desired components thereby causing their rectilinear motion toward the separation membrane's outer periphery for sequestration.
- It is still another aspect of the first embodiment of the present invention to provide the periodic charge effecting migration of desired molecules by controlling a standing wave emanating from the membrane's inner diameter to the membrane's outer diameter, and thereby causing their rectilinear motion toward the separation membrane's outer periphery for sequestration.
- It is another aspect of the present invention to provide a method for separating molecular components from an aqueous solution, comprising positioning a porous separation membrane in a chamber, flowing an aqueous solution on to the separation membrane, and applying an electrical charge to the separation membrane to migrate components of the aqueous solution blocked by the separation membrane to an outer periphery thereof.
- It is still another aspect of the present invention for the above embodiment to provide for controlling the flow of the aqueous solution with a pump, and controlling application of the electrical charge with a charging device.
- It is yet another aspect of the present invention for the above embodiment to provide for controlling the flow and application of electrical charge simultaneously to move the blocked components of aqueous solution, or to provide for applying the electrical charge periodically in a tuned asymmetric normal mode of the blocked components thereby causing their rectilinear motion toward the separation membrane's outer periphery, or to provide for applying the electrical charge periodically to effect migration of the blocked components in a standing wave emanating from the membrane's inner diameter to the membrane's outer diameter, thereby causing rectilinear motion of the blocked components toward the membrane's outer periphery for sequestration.
- In the alternative, the above embodiment could provide for collecting the migrated components in at least one collection well disposed on the separation membrane's outer periphery, or provide for utilizing perforated graphene as the porous separation membrane.
- These and other features and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings wherein:
-
FIG. 1 is a schematic drawing of a molecular separation device according to the concepts of the present invention; -
FIG. 2 is a schematic drawing of a chamber maintaining a separation membrane according to the concepts of the present invention; -
FIG. 3 is schematic representation of a protein collected by the separation membrane according to the concepts of the present invention; and -
FIG. 4 illustrates the “walking” or charged migration of the protein during operation of the device according to the concepts of the present invention. - Referring now to
FIG. 1 , it can be seen that a molecular separation device according to the concepts of the present invention is designated generally by thenumeral 10. Thedevice 10 includes achamber 12 which at one end has aninlet 14 for receiving an aqueous suspension which contains the material or component which is to be removed. In the present embodiment, proteins are to be separated from the suspension. Thechamber 12 also provides for anoutlet 16, opposite the inlet, in which the secondary products or the “unfiltered” products are exhausted or drained from the chamber. - A
separation membrane 18 is held by thechamber 12 so as to be orthogonal to the flow of the aqueous suspension. In the present embodiment, the separation membrane is a porous material such as a carbon membrane. In yet another embodiment, a graphene membrane is used, and in other embodiments multiple layers of graphene material may be used. - In the present embodiment, the
separation membrane 18 is a graphene membrane as described in U.S. Pat. No. 8,361,321, which is incorporated herein by reference. The graphene membrane is a single-atomic-layer-thick layer of carbon atoms, bound together to define a sheet. The thickness of a single graphene membrane, which may be referred to as a layer or a sheet, is approximately 0.2 to 0.3 nanometers (nm). In some embodiments, multiple graphene layers can be formed, having greater thickness and correspondingly greater strength. Multiple graphene sheets can be provided in multiple layers as the membrane is grown or formed, and is commonly known as few layer graphene. Or multiple graphene sheets can be achieved by layering or positioning one graphene layer on top of another. For all the embodiments disclosed herein, a single layer of graphene or multiple graphene layers may be used. Testing reveals that multiple layers of graphene maintain their integrity and function, possibly as a result of self-adhesion. This improves the strength of the membrane and in some cases flow performance. The perforated graphene high-flux throughput material provides significantly improved filtration properties, as opposed to polyamide or other polymeric material filtration materials. The carbon atoms of the graphene layer define a repeating pattern of hexagonal ring structures (benzene rings) constructed of six carbon atoms, which form a honeycomb lattice of carbon atoms. An interstitial aperture is formed by each six carbon atom ring structure in the sheet and this interstitial aperture is less than one nanometer across. Indeed, skilled artisans will appreciate that the interstitial aperture is believed to be about 0.23 nanometers across at its longest dimension. Accordingly, the dimension and configuration of the interstitial aperture and the electron nature of the graphene precludes transport of any molecule across the graphene's thickness unless there are perforations. This dimension is much too small to allow the passage of either water or ions. - In order to form the perforated graphene membrane, one or more perforations are made. A representative generally or nominally round aperture or
perforation 19 is defined through thegraphene membrane 18. The generally round shape of theaperture 19 is affected by the fact that the edges of the aperture are defined, in part, by the hexagonal carbon ring structure of thegraphene membrane 18. Aperture sizes may be selected depending upon the constituents of the received aqueous suspension and the constituents or components of the suspension that is desired to be blocked or filtered. Accordingly, theapertures 19 may range in size from 0.5 nm to 1.2 nm in some embodiments, or from 1.0 to 10 nm in other embodiments. And in other embodiments, the size of the apertures may range from 10 nm to 100 nm. Some apertures may be about 20 nm in some embodiments and about 50 nm in diameter in other embodiments. - Apertures in the graphene membrane may be made by selective oxidation, by which is meant exposure to an oxidizing agent for a selected period of time. It is believed that the aperture 312 can also be laser-drilled. As described in the publication Nano Lett. 2008, Vol. 8, no. 7, pg 1965-1970, the most straightforward perforation strategy is to treat the graphene film with dilute oxygen in argon at elevated temperature. As described therein, through apertures or holes in the 20 to 180 nm range were etched in graphene using 350 mTorr of oxygen in 1 atmosphere (atm) argon at 500° C. for 2 hours. The paper reasonably suggests that the number of holes is related to defects in the graphene sheet and the size of the holes is related to the residence time. This is believed to be the preferred method for making the desired perforations in graphene structures. The structures may be graphene nanoplatelets and graphene nanoribbons. Thus, apertures in the desired range can be formed by shorter oxidation times. Another more involved method as described in Kim et al. “Fabrication and Characterization of Large Area, Semiconducting Nanoperforated Graphene Materials,” Nano Letters 2010 Vol. 10, No. 4, Mar. 1, 2010, pp 1125-1131 utilizes a self assembling polymer that creates a mask suitable for patterning using reactive ion etching. A P(S-blockMMA) block copolymer forms an array of PMMA columns that form vias for the RIE upon redeveloping. The pattern of holes is very dense. The number and size of holes is controlled by the molecular weight of the PMMA block and the weight fraction of the PMMA in the P(S-MMA). Either method has the potential to produce perforated graphene sheets. Other methods of forming the apertures may be employed. In the embodiments disclosed herein, it will be appreciated that the apertures are sized to block selected components of the suspension and allow passage of other components. Moreover, the edges of the apertures may be modified to assist in blocking or passing of selected components.
- A charging device, designated generally by the numeral 20, is connected to the
separation membrane 18 so as to selectively apply an electrical charge to the material as the aqueous suspension is flowing through the material. Details of this process will be described as the description proceeds. - A
pump 24 may be coupled to theinlet 14 so as to control the flow of the aqueous suspension through thechamber 12. - The charging
device 20 includes a controller designated generally by the numeral 28. Skilled artisans will appreciate that thecontroller 28 includes the necessary hardware, software, memory, and functionalities to control operation of thepump 24 and theseparation membrane 18 so as to operate the device in a manner to be described. Connected to thecontroller 28 is an input/output device 30 such as a keyboard so as to allow for a technician to operate thedevice 10. This may be done by controlling the operation of the pump so as to control the amount of suspension flowing through the chamber and/or the operation of the charging device so as to control the amount of electrical voltage and/or current applied to theseparation membrane 18. Generally, thecontroller 28 sends an appropriate control signal through a digital/analog converter 32, which generates a charge gradient that is applied to a drivingcircuit 34. The drivingcircuit 34 generates signals that are delivered along driving leads 36A and 36B to locations on theseparation membrane 18. Aground connection 40 is provided to connect the separation membrane to ground while areturn lead 42 is also connected to the separation membrane so as to provide a way of monitoring the status of the separation membrane during operation. In particular, thereturn lead 42 is connected to an analog/digital converter 44 which delivers a digital signal back to thecontroller 28 for observation by a technician. - As best seen in
FIG. 2 , thechamber 12 orthogonally maintains theseparation membrane 18 so as to be fully exposed to the suspension flowing through the chamber. Skilled artisans will appreciate that themembrane 18 is carried or supported by appropriate ledges, ridges or any other support structure maintained within thechamber 12. A polymeric supporting layer with openings much larger thanapertures 19 may also be positioned underneath the membrane. Positioned about the outer circumference of the separation membrane aremicro-capture wells 50 which allow for collection of the proteins that are blocked or collected by the separation membrane. Thesewells 50 are coupled to captureconduits 52 which deliver the desired protein material to acollection vessel 54. The remaining uncaptured material exits theoutlet 16. - In operation, the separation membrane is a sterile, hydrophobic, selectively perforated and charge bearing material. The size of the perforations or
apertures 19 are selected in accordance with the best known practice for size exclusion i.e. passing, of unwanted material together with desired sequestration (capture) of the desired class of target proteins. Skilled artisans will appreciate that the aqueous suspension is crudely centrifuged or pre-filtered to remove the largest and ineffective protein sequastra i.e. the undesired and potentially membrane clogging mixture or components. As noted previously, the separation membrane is positioned orthogonally to the bulk mix flow of the aqueous suspension. In some embodiments, the suspension could be a solvated plasma that includes the desired protein of interest. Accordingly, the suspension flows past the separation member and permits transport of unwanted smaller auxiliary proteins together with a class of target proteins for harvest. This will result in a distribution of both target and unwanted proteins against the separation membrane by convective pressure force. In some embodiments, the suspension may be directed tangentially along the surface of themembrane 18. Those components in the suspension smaller than theapertures 19 flow through the membrane and are processed accordingly. - The present invention utilizes the electro-mechanically excited response of biologically active proteins that are commonly used for static constant potential (voltage) electrophoresis separation methods. In the present embodiment, the driving
circuit 34 excites theseparation membrane 18 and generates a periodic electrical charge over time to gradually migrate specific individual proteins of interest—identified asprotein 60—that are held by the separation membrane to the outer circumference of the membrane as schematically represented inFIG. 3 . Indeed, application of a selected charge to theleads 36A,B at selective times allows for generation of the “walking” movements of the proteins. For example, charges may intermittently be applied to each lead so as to initiate the walking action of the protein. Accordingly, by using specific charge versus time excitation of the anti-symmetric protein mode together with synchronized convective flow pressure generated by thepump 24, which allows for normal force capturing of the charge protein at each temporal step, the selected proteins of interest are driven to the external circumference of separation membrane. In other words, application of a charge causes one end of the protein to extend outwardly toward the periphery of the membrane. Removal of the charge causes the end of the protein that did not move during the application of the charge to migrate toward the end of the protein that did move. Application of a periodic charge is believed to be suitable for proteins that are of a tubular or string-like shape. - In another aspect of the present embodiment, the aforementioned charges themselves may be generated in a standing wave pattern by the driving
circuit 34 whose net outward motion may be caused by appropriate control of the charge phasing. As a result, theprotein 16 effectively rides the wave as it moves outwardly to the periphery of themembrane 18. Application of a standing wave is believed to be suitable for proteins that are of a spherical or globular shape. Once the proteins are driven to the circumference, they flow into the U-shaped capture well 50 as they are driven by weak gravitation and Van der Waals forces so as to capture and concentrate the selected protein. - The
controller 28 together with the drivingcircuit 34 provides for effectively producing the desired charge in space and time needed to migrate these specific proteins across the separation membrane to thecapture wells 50. The material then migrates from the wells through the conduits into theappropriate retention vessel 54. In other words, periodic electrical charge effecting migration of desired molecules orproteins 60 is tuned to asymmetric normal modes of the desired components, thereby causing their rectilinear motion toward the separation membrane's outer periphery for sequestration. Or, in the alternative, the periodic charge effecting migration of desired molecules orproteins 60 is controlled by a standing wave emanating from the membrane's inner diameter to the membrane's outer diameter, and thereby causing their rectilinear motion toward the separation membrane's periphery for sequestration. - In some embodiments the separation membrane is a monatomic carbon graphene membrane with a selected hole diameter and spacing. By application of subsequent temporal electrical charges to the membrane, very specific and selective forcing of the desired harvested molecules and/or proteins take place along the separation membrane surface so that they migrate to an awaiting capture basin at the outer circumference. As schematically represented in
FIG. 4 , one end of theprotein 60, which is larger than theaperture 19, extends toward the outer periphery of the membrane. The protein is moved by the alternating charge generating a second harmonic mode that causes a temporary physical change in the protein's shape. Eventually, the other end of the protein detaches with little or no damage from the surface of the membrane and moves toward the first end of the protein. This process repeats until the protein is captured in thewell 50. This is represented inFIG. 4 by the time sequence A through E, where A represents the initial application of charge and E represents the last removal of charge as the protein reaches the membrane's outer periphery. - By controlling the hole diameter and the charge versus time profile, the
device 10 obtains an accurate selectivity, purity and throughput not obtainable by prior art devices. Applications of this device include but are not limited to pharamacologic, hydrocarbon slurry refining and biomedical. Pharamacological applications allow for retrieval of high-value proteins from large amounts of water. The hydrocarbon slurry refining allows for stage filters based on hydrocarbon chain size in a micro-refinery fashion instead of heat/energy intensive distillation processes. The biomedical process allows for use of thedevice 10 in dialysis filters so as to filter impurities from the bloodstream. - By reducing material thicknesses to one atom such as in a graphene separation membrane, flow resistance and surface friction are significantly decreased compared to current art membranes thereby lowering the required pump pressure and energy. This attribute, together with the membrane's unique large conductivity to support a time-dependent charge permits a high efficiency, selective, active retention/harvest membrane system. Additionally, with the combination of lower surface friction and high conductivity, larger unwanted compounds can be quickly removed from the graphene membrane material significantly reducing fouling of the filtration component.
- Skilled artisans will appreciated that the disclosed device provides for creating a biological material filtration and isolation membrane that allows for unique, predictable and efficient migration of selected and specified biologically active proteins into sequestration upon demand. The device is also capable of controlling the precise molecular and electro-active nature of the required target molecules. It is further believed that the disclosed device can operate at significantly improved rates and quantity efficiency compared to current devices.
- Thus, it can be seen that the objects of the invention have been satisfied by the structure and its method for use presented above. While in accordance with the Patent Statutes, only the best mode and preferred embodiment has been presented and described in detail, it is to be understood that the invention is not limited thereto or thereby. Accordingly, for an appreciation of the true scope and breadth of the invention, reference should be made to the following claims.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/686,452 US20150218210A1 (en) | 2012-03-21 | 2015-04-14 | Molecular separation device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261613578P | 2012-03-21 | 2012-03-21 | |
US13/804,085 US9028663B2 (en) | 2012-03-21 | 2013-03-14 | Molecular separation device |
US14/686,452 US20150218210A1 (en) | 2012-03-21 | 2015-04-14 | Molecular separation device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/804,085 Continuation US9028663B2 (en) | 2012-03-21 | 2013-03-14 | Molecular separation device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150218210A1 true US20150218210A1 (en) | 2015-08-06 |
Family
ID=48050312
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/804,085 Expired - Fee Related US9028663B2 (en) | 2012-03-21 | 2013-03-14 | Molecular separation device |
US14/686,452 Abandoned US20150218210A1 (en) | 2012-03-21 | 2015-04-14 | Molecular separation device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/804,085 Expired - Fee Related US9028663B2 (en) | 2012-03-21 | 2013-03-14 | Molecular separation device |
Country Status (12)
Country | Link |
---|---|
US (2) | US9028663B2 (en) |
EP (1) | EP2827974A1 (en) |
JP (2) | JP2015511531A (en) |
KR (1) | KR20140147855A (en) |
CN (2) | CN104245094A (en) |
AU (2) | AU2013235234A1 (en) |
CA (1) | CA2865648A1 (en) |
IL (1) | IL234685A0 (en) |
IN (1) | IN2014DN07731A (en) |
SA (1) | SA113340401B1 (en) |
SG (1) | SG11201405347PA (en) |
WO (1) | WO2013142539A1 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150258498A1 (en) * | 2014-03-12 | 2015-09-17 | Lockheed Martin Corporation | Graphene-based molecular separation and sequestration device and methods for harvest and recovery |
US9463421B2 (en) | 2012-03-29 | 2016-10-11 | Lockheed Martin Corporation | Planar filtration and selective isolation and recovery device |
US9475709B2 (en) | 2010-08-25 | 2016-10-25 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US9480952B2 (en) | 2013-03-14 | 2016-11-01 | Lockheed Martin Corporation | Methods for chemical reaction perforation of atomically thin materials |
US9505192B2 (en) | 2013-03-13 | 2016-11-29 | Lockheed Martin Corporation | Nanoporous membranes and methods for making the same |
US9567224B2 (en) | 2012-03-21 | 2017-02-14 | Lockheed Martin Corporation | Methods for perforating graphene using an activated gas stream and perforated graphene produced therefrom |
US9572918B2 (en) | 2013-06-21 | 2017-02-21 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
US9844757B2 (en) | 2014-03-12 | 2017-12-19 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US9870895B2 (en) | 2014-01-31 | 2018-01-16 | Lockheed Martin Corporation | Methods for perforating two-dimensional materials using a broad ion field |
US10005038B2 (en) | 2014-09-02 | 2018-06-26 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
US10017852B2 (en) | 2016-04-14 | 2018-07-10 | Lockheed Martin Corporation | Method for treating graphene sheets for large-scale transfer using free-float method |
US10118130B2 (en) | 2016-04-14 | 2018-11-06 | Lockheed Martin Corporation | Two-dimensional membrane structures having flow passages |
US10203295B2 (en) | 2016-04-14 | 2019-02-12 | Lockheed Martin Corporation | Methods for in situ monitoring and control of defect formation or healing |
US10201784B2 (en) | 2013-03-12 | 2019-02-12 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
US10213746B2 (en) | 2016-04-14 | 2019-02-26 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
US10376845B2 (en) | 2016-04-14 | 2019-08-13 | Lockheed Martin Corporation | Membranes with tunable selectivity |
US10418143B2 (en) | 2015-08-05 | 2019-09-17 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
US10500546B2 (en) | 2014-01-31 | 2019-12-10 | Lockheed Martin Corporation | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
US10696554B2 (en) | 2015-08-06 | 2020-06-30 | Lockheed Martin Corporation | Nanoparticle modification and perforation of graphene |
US10980919B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9193587B2 (en) | 2011-07-13 | 2015-11-24 | Lockheed Martin Corporation | System and method for water purification and desalination |
US9095823B2 (en) * | 2012-03-29 | 2015-08-04 | Lockheed Martin Corporation | Tunable layered membrane configuration for filtration and selective isolation and recovery devices |
US9067811B1 (en) * | 2012-05-25 | 2015-06-30 | Lockheed Martin Corporation | System, method, and control for graphenoid desalination |
CN106232103A (en) * | 2014-03-12 | 2016-12-14 | 洛克希德马丁公司 | Internal and the in vitro use of Graphene |
US20180021499A1 (en) * | 2015-02-06 | 2018-01-25 | Cabot Corporation | Urea sequestration compositions and methods |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040121488A1 (en) * | 2002-09-11 | 2004-06-24 | Chang Frank N. | System and methods for electrophoretic separation of proteins on protein binding membranes |
US20080156648A1 (en) * | 2005-03-18 | 2008-07-03 | Bayer Technology Services Gmbh | Electrofiltration Method |
US20110056892A1 (en) * | 2009-09-08 | 2011-03-10 | Teledyne Scientific & Imaging, Llc | Macrocyclic pore-apertured carbon nanotube apparatus |
US20120183738A1 (en) * | 2008-03-24 | 2012-07-19 | The Regents Of The University Of California | Graphene-based structure, method of suspending graphene membrane, and method of depositing material onto graphene membrane |
US8361321B2 (en) * | 2010-08-25 | 2013-01-29 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US20130190476A1 (en) * | 2010-07-28 | 2013-07-25 | Thomas M. Lancaster | Recombinantly expressed insulin polypeptides and uses thereof |
US20130192461A1 (en) * | 2012-01-27 | 2013-08-01 | Empire Technology Development, Llc | Accelerating transport through graphene membranes |
US9067811B1 (en) * | 2012-05-25 | 2015-06-30 | Lockheed Martin Corporation | System, method, and control for graphenoid desalination |
US20160282326A1 (en) * | 2013-11-25 | 2016-09-29 | Northeastern University | Freestanding Ultrathin Membranes and Transfer-Free Fabrication Thereof |
US9475709B2 (en) * | 2010-08-25 | 2016-10-25 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US9567224B2 (en) * | 2012-03-21 | 2017-02-14 | Lockheed Martin Corporation | Methods for perforating graphene using an activated gas stream and perforated graphene produced therefrom |
US9572918B2 (en) * | 2013-06-21 | 2017-02-21 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
US9592475B2 (en) * | 2013-03-12 | 2017-03-14 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
US9610546B2 (en) * | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA26028A1 (en) | 1997-01-09 | 2004-04-01 | Garfield Int Invest Ltd | DESALINATION OF WATER |
GB0100513D0 (en) | 2001-01-09 | 2001-02-21 | Smithkline Beecham Plc | Process |
JP3939943B2 (en) | 2001-08-29 | 2007-07-04 | 株式会社Gsiクレオス | Filter material made of carbon fiber by vapor deposition |
US7166443B2 (en) | 2001-10-11 | 2007-01-23 | Aviva Biosciences Corporation | Methods, compositions, and automated systems for separating rare cells from fluid samples |
US7150813B2 (en) * | 2003-06-12 | 2006-12-19 | Palo Alto Research Center Incorporated | Isoelectric focusing (IEF) of proteins with sequential and oppositely directed traveling waves in gel electrophoresis |
US7410574B2 (en) | 2004-03-03 | 2008-08-12 | Patent Innovations Llc | Magnetic particle filtration apparatus |
DE102004062535A1 (en) | 2004-12-24 | 2006-07-06 | Forschungszentrum Karlsruhe Gmbh | Semipermeable membrane system for magnetic particle fractions |
US20100059378A1 (en) | 2007-07-18 | 2010-03-11 | The Water Company Llc | Apparatus and method for removal of ions from a porous electrode that is part of a deionization system |
US8698481B2 (en) | 2007-09-12 | 2014-04-15 | President And Fellows Of Harvard College | High-resolution molecular sensor |
US8147599B2 (en) | 2009-02-17 | 2012-04-03 | Mcalister Technologies, Llc | Apparatuses and methods for storing and/or filtering a substance |
EP2230511B1 (en) | 2009-03-20 | 2017-04-26 | Ecole Polytechnique | Method for varying the diameter of a nanopore contained in a nanoporous membrane functionalised with a ph-dependent polyelectrolyte |
CN102574059B (en) | 2009-08-10 | 2014-12-10 | 丹尼斯科美国公司 | Cross-flow membrane filtration-based process for protein recovery |
BR112012005888B1 (en) * | 2009-09-18 | 2019-10-22 | Harvard College | graphene nanopore sensors and method for evaluating a polymer molecule |
US9901881B2 (en) | 2009-11-25 | 2018-02-27 | Cms Innovations Pty Ltd | Membrane and membrane separation system |
EP2593403B1 (en) | 2010-07-14 | 2020-03-04 | Monash University | Method for producing a gel film and filtration membrane prepared with this method |
WO2012030368A1 (en) | 2010-09-01 | 2012-03-08 | Lawrence Curtin | Application of radio frequency to fluidized beds |
KR101211850B1 (en) | 2010-09-01 | 2012-12-12 | 연세대학교 산학협력단 | net of Graphene nano filter, Graphene nano filter and manufacturing method |
CN102242062B (en) * | 2011-04-19 | 2012-12-19 | 浙江大学 | High-resolution biosensor |
CN104411642B (en) * | 2012-03-15 | 2018-04-03 | 麻省理工学院 | Filter based on graphene |
-
2013
- 2013-03-14 US US13/804,085 patent/US9028663B2/en not_active Expired - Fee Related
- 2013-03-20 CN CN201380014845.XA patent/CN104245094A/en active Pending
- 2013-03-20 AU AU2013235234A patent/AU2013235234A1/en not_active Abandoned
- 2013-03-20 KR KR1020147029539A patent/KR20140147855A/en not_active Application Discontinuation
- 2013-03-20 IN IN7731DEN2014 patent/IN2014DN07731A/en unknown
- 2013-03-20 JP JP2015501867A patent/JP2015511531A/en active Pending
- 2013-03-20 SA SA113340401A patent/SA113340401B1/en unknown
- 2013-03-20 CA CA2865648A patent/CA2865648A1/en not_active Abandoned
- 2013-03-20 SG SG11201405347PA patent/SG11201405347PA/en unknown
- 2013-03-20 CN CN201710120140.6A patent/CN106823846A/en active Pending
- 2013-03-20 WO PCT/US2013/033035 patent/WO2013142539A1/en active Application Filing
- 2013-03-20 EP EP13714806.0A patent/EP2827974A1/en not_active Withdrawn
-
2014
- 2014-09-16 IL IL234685A patent/IL234685A0/en unknown
-
2015
- 2015-04-14 US US14/686,452 patent/US20150218210A1/en not_active Abandoned
-
2017
- 2017-01-11 JP JP2017002652A patent/JP2017100127A/en active Pending
-
2018
- 2018-01-05 AU AU2018200090A patent/AU2018200090A1/en not_active Abandoned
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040121488A1 (en) * | 2002-09-11 | 2004-06-24 | Chang Frank N. | System and methods for electrophoretic separation of proteins on protein binding membranes |
US20080156648A1 (en) * | 2005-03-18 | 2008-07-03 | Bayer Technology Services Gmbh | Electrofiltration Method |
US20120183738A1 (en) * | 2008-03-24 | 2012-07-19 | The Regents Of The University Of California | Graphene-based structure, method of suspending graphene membrane, and method of depositing material onto graphene membrane |
US20110056892A1 (en) * | 2009-09-08 | 2011-03-10 | Teledyne Scientific & Imaging, Llc | Macrocyclic pore-apertured carbon nanotube apparatus |
US20130190476A1 (en) * | 2010-07-28 | 2013-07-25 | Thomas M. Lancaster | Recombinantly expressed insulin polypeptides and uses thereof |
US9475709B2 (en) * | 2010-08-25 | 2016-10-25 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US8361321B2 (en) * | 2010-08-25 | 2013-01-29 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US20130192461A1 (en) * | 2012-01-27 | 2013-08-01 | Empire Technology Development, Llc | Accelerating transport through graphene membranes |
WO2013115762A1 (en) * | 2012-01-27 | 2013-08-08 | Empire Technology Development, Llc | Accelerating transport through graphene membranes |
US9567224B2 (en) * | 2012-03-21 | 2017-02-14 | Lockheed Martin Corporation | Methods for perforating graphene using an activated gas stream and perforated graphene produced therefrom |
US9067811B1 (en) * | 2012-05-25 | 2015-06-30 | Lockheed Martin Corporation | System, method, and control for graphenoid desalination |
US9592475B2 (en) * | 2013-03-12 | 2017-03-14 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
US9572918B2 (en) * | 2013-06-21 | 2017-02-21 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
US20160282326A1 (en) * | 2013-11-25 | 2016-09-29 | Northeastern University | Freestanding Ultrathin Membranes and Transfer-Free Fabrication Thereof |
US9610546B2 (en) * | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
Non-Patent Citations (2)
Title |
---|
Handbood of Separation Techniques for Chemical Engineers, Philip A. Schweitzwer, Mc Graw Hill, 1979, pages 5-2-5-18. (Year: 1979) * |
Myunwoong Kim, et al, Fabrication and characterization of Large -Area, Semiconducting Nanoperforated Graphene Materials, American Chemical Society 2010, 10, 1125-1131. * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9475709B2 (en) | 2010-08-25 | 2016-10-25 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US9833748B2 (en) | 2010-08-25 | 2017-12-05 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US9567224B2 (en) | 2012-03-21 | 2017-02-14 | Lockheed Martin Corporation | Methods for perforating graphene using an activated gas stream and perforated graphene produced therefrom |
US9463421B2 (en) | 2012-03-29 | 2016-10-11 | Lockheed Martin Corporation | Planar filtration and selective isolation and recovery device |
US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
US10201784B2 (en) | 2013-03-12 | 2019-02-12 | Lockheed Martin Corporation | Method for forming perforated graphene with uniform aperture size |
US9505192B2 (en) | 2013-03-13 | 2016-11-29 | Lockheed Martin Corporation | Nanoporous membranes and methods for making the same |
US9480952B2 (en) | 2013-03-14 | 2016-11-01 | Lockheed Martin Corporation | Methods for chemical reaction perforation of atomically thin materials |
US9572918B2 (en) | 2013-06-21 | 2017-02-21 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
US10471199B2 (en) | 2013-06-21 | 2019-11-12 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
US9870895B2 (en) | 2014-01-31 | 2018-01-16 | Lockheed Martin Corporation | Methods for perforating two-dimensional materials using a broad ion field |
US10500546B2 (en) | 2014-01-31 | 2019-12-10 | Lockheed Martin Corporation | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
US20150258498A1 (en) * | 2014-03-12 | 2015-09-17 | Lockheed Martin Corporation | Graphene-based molecular separation and sequestration device and methods for harvest and recovery |
US9844757B2 (en) | 2014-03-12 | 2017-12-19 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US10005038B2 (en) | 2014-09-02 | 2018-06-26 | Lockheed Martin Corporation | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same |
US10418143B2 (en) | 2015-08-05 | 2019-09-17 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
US10696554B2 (en) | 2015-08-06 | 2020-06-30 | Lockheed Martin Corporation | Nanoparticle modification and perforation of graphene |
US10118130B2 (en) | 2016-04-14 | 2018-11-06 | Lockheed Martin Corporation | Two-dimensional membrane structures having flow passages |
US10376845B2 (en) | 2016-04-14 | 2019-08-13 | Lockheed Martin Corporation | Membranes with tunable selectivity |
US10213746B2 (en) | 2016-04-14 | 2019-02-26 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
US10203295B2 (en) | 2016-04-14 | 2019-02-12 | Lockheed Martin Corporation | Methods for in situ monitoring and control of defect formation or healing |
US10017852B2 (en) | 2016-04-14 | 2018-07-10 | Lockheed Martin Corporation | Method for treating graphene sheets for large-scale transfer using free-float method |
US10981120B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
US10980919B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
Also Published As
Publication number | Publication date |
---|---|
CA2865648A1 (en) | 2013-09-26 |
AU2018200090A1 (en) | 2018-01-25 |
SA113340401B1 (en) | 2015-08-16 |
CN104245094A (en) | 2014-12-24 |
JP2017100127A (en) | 2017-06-08 |
EP2827974A1 (en) | 2015-01-28 |
IN2014DN07731A (en) | 2015-05-15 |
SG11201405347PA (en) | 2014-10-30 |
US20130248367A1 (en) | 2013-09-26 |
US9028663B2 (en) | 2015-05-12 |
AU2013235234A1 (en) | 2014-10-16 |
JP2015511531A (en) | 2015-04-20 |
KR20140147855A (en) | 2014-12-30 |
CN106823846A (en) | 2017-06-13 |
WO2013142539A1 (en) | 2013-09-26 |
IL234685A0 (en) | 2014-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9028663B2 (en) | Molecular separation device | |
US10005038B2 (en) | Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same | |
US10653824B2 (en) | Two-dimensional materials and uses thereof | |
US20190029793A1 (en) | Implantable systems and methods for removing specific impurities from fluids such as blood | |
US20170296706A1 (en) | Methods for in vivo and in vitro use of graphene and other two-dimensional materials | |
KR870001735B1 (en) | Purification method of water | |
DE69942508D1 (en) | METHOD AND DEVICE FOR SIZE DEPENDENT SEPARATION OF MICRO AND NANOPARTICLES | |
US10118130B2 (en) | Two-dimensional membrane structures having flow passages | |
US9956529B2 (en) | Microfabricated ion-selective filter for filtration of ions and molecules | |
US10717052B2 (en) | Hybrid type filtration structure for filtering liquid | |
CN206027245U (en) | Control structure that micron and centrifugal filtration of submicron granule were collected | |
WO2018201038A1 (en) | Controlling translocating molecules through a nanopore | |
CN102908907A (en) | Preparation method of ultrathin polymer separation membrane | |
JP4917792B2 (en) | Method for estimating the degree of contamination of separation membranes used in membrane separation activated sludge equipment. | |
EP3110467B1 (en) | Cell filter separation system | |
CN105582815A (en) | Membrane protein based composite membrane | |
TWI325761B (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LOCKHEED MARTIN CORPORATION, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STETSON, JOHN B., JR.;SIMON, SARAH;REEL/FRAME:037287/0244 Effective date: 20151014 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |